TNFRSF9 and otitis media with effusion: Table 4 and Supplementary Figure S6 presented the base-case results for a duration of 1 year: OME had the lowest expected total cost ($53023.30) for 10,000 Chinese patients with DU, followed by PAN, LAN, RAB, and ILA.